Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Primary Cutaneous Large B-Cell Lymphomas: relevance of the 2017 WHO Classification.

Menguy S, Beylot-Barry M, Marie P, Pham Ledard A, Frison E, Comoz F, Battistella M, Szablewski V, Balme B, Croue A, Franck F, Ortonne N, Tournier E, Lamant L, Carlotti A, De Muret A, Le Gall F, Lorton MH, Merlio JP, Vergier B.

Histopathology. 2019 Feb 4. doi: 10.1111/his.13832. [Epub ahead of print]

PMID:
30715765
2.

Blockade of crizotinib-induced BCL2 elevation in ALK-positive anaplastic large cell lymphoma triggers autophagy associated with cell death.

Torossian A, Broin N, Frentzel J, Daugrois C, Gandarillas S, Al Saati T, Lamant L, Brousset P, Giuriato S, Espinos E.

Haematologica. 2019 Jan 24. pii: haematol.2017.181966. doi: 10.3324/haematol.2017.181966. [Epub ahead of print]

3.

miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.

Hoareau-Aveilla C, Quelen C, Congras A, Caillet N, Labourdette D, Dozier C, Brousset P, Lamant L, Meggetto F.

Haematologica. 2019 Feb;104(2):347-359. doi: 10.3324/haematol.2018.195131. Epub 2018 Sep 27.

4.

Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?

Gaspard M, Lamant L, Tournier E, Valentin T, Rochaix P, Terrier P, Ranchere-Vince D, Coindre JM, Filleron T, Le Guellec S.

Histopathology. 2018 Dec;73(6):969-982. doi: 10.1111/his.13740. Epub 2018 Oct 23.

PMID:
30137667
5.

Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF-V600 + MEK Inhibitors for Advanced Melanoma.

Lucas P, Boulinguez S, Sibaud V, Mourey L, Lamant L, Paul C, Meyer N.

Dermatology. 2018;234(3-4):92-98. doi: 10.1159/000490891. Epub 2018 Aug 15.

PMID:
30110681
6.

Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock.

Casassa EA, Mailhol C, Tournier E, Laurent C, Degboe Y, Eischen M, Kirsten N, Moreau J, Evrard SM, Mansat-De Mas V, Lamant L, Dubreuil P, Apoil PA, Hermine O, Paul C, Bulai Livideanu C.

Allergol Int. 2019 Jan;68(1):119-121. doi: 10.1016/j.alit.2018.07.003. Epub 2018 Aug 7. No abstract available.

7.

[Dermatopathology histoseminar. Case 6].

Lamant L.

Ann Pathol. 2018 Aug;38(4):241-244. doi: 10.1016/j.annpat.2018.05.008. Epub 2018 Jul 3. French. No abstract available.

PMID:
29980306
8.

[Dermatopathology histoseminar. Case 5].

Lamant L.

Ann Pathol. 2018 Aug;38(4):236-240. doi: 10.1016/j.annpat.2018.05.009. Epub 2018 Jul 3. French. No abstract available.

PMID:
29980305
9.

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy.

Dupuis F, Lamant L, Gerard E, Torossian N, Chaltiel L, Filleron T, Beylot-Barry M, Dutriaux C, Prey S, Gros A, Jullie ML, Meyer N, Vergier B.

Br J Cancer. 2018 Jul;119(2):193-199. doi: 10.1038/s41416-018-0168-9. Epub 2018 Jul 5.

PMID:
29973670
10.

[Dermatopathology histoseminar: Introduction].

Fraitag S, Lamant L.

Ann Pathol. 2018 Aug;38(4):207-209. doi: 10.1016/j.annpat.2018.05.003. Epub 2018 Jun 13. French. No abstract available.

PMID:
29908855
11.

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.

Russano de Paiva Silva G, Tournier E, Sarian LO, Bulai-Livideanu C, Delsol G, Lamant L, Vassallo J, Brousset P, Laurent C.

Medicine (Baltimore). 2018 May;97(21):e10642. doi: 10.1097/MD.0000000000010642.

12.

[Dermatologic toxicities of immune checkpoint inhibitors].

Sibaud V, Boulinguez S, Pagès C, Riffaud L, Lamant L, Chira C, Boyrie S, Vigarios E, Tournier E, Meyer N.

Ann Dermatol Venereol. 2018 May;145(5):313-330. doi: 10.1016/j.annder.2018.01.047. Epub 2018 Apr 18. Review. French.

PMID:
29678394
13.

Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge.

Perron E, Pissaloux D, Charon Barra C, Karanian M, Lamant L, Parfait S, Alberti L, de la Fouchardière A.

Am J Surg Pathol. 2018 May;42(5):595-603. doi: 10.1097/PAS.0000000000000973.

PMID:
29635259
14.

Doxorubicin-induced loss of DNA topoisomerase II and DNMT1- dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells.

Congras A, Caillet N, Torossian N, Quelen C, Daugrois C, Brousset P, Lamant L, Meggetto F, Hoareau-Aveilla C.

Oncotarget. 2018 Feb 8;9(18):14539-14551. doi: 10.18632/oncotarget.24465. eCollection 2018 Mar 6.

15.

Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum.

Salomon G, Maza A, Boulinguez S, Paul C, Lamant L, Tournier E, Mazereeuw-Hautier J, Meyer N.

Br J Dermatol. 2018 May;178(5):1199-1203. doi: 10.1111/bjd.16270. Epub 2018 Feb 26.

PMID:
29274233
16.

[Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].

Casassa EA, Nicol P, Viraben R, Gaudin C, Bulai Livideanu C, Mengelle C, Lamant L, Fortenfant F, Paul C, Konstantinou MP.

Ann Dermatol Venereol. 2018 Mar;145(3):182-186. doi: 10.1016/j.annder.2017.10.013. Epub 2017 Dec 6. French.

PMID:
29221652
17.

Trichodysplasia spinulosa associated with HIV infection: clinical response to acitretin and valganciclovir.

Aleissa M, Konstantinou MP, Samimi M, Lamant L, Gaboriaud P, Touze A, Ceppi C, Bulai Livideanu C, Paul C.

Clin Exp Dermatol. 2018 Mar;43(2):231-233. doi: 10.1111/ced.13286. Epub 2017 Oct 13. No abstract available.

PMID:
29028114
18.

Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.

Le Guellec S, Macagno N, Velasco V, Lamant L, Lae M, Filleron T, Malissen N, Cassagnau E, Terrier P, Chevreau C, Ranchere-Vince D, Coindre JM.

Mod Pathol. 2017 Dec;30(12):1677-1687. doi: 10.1038/modpathol.2017.91. Epub 2017 Jul 28.

19.

Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.

Morel A, Brière J, Lamant L, Loschi M, Haioun C, Delarue R, Tournilhac O, Bachy E, Sonet A, Amorim S, Laurent C, Gaulard P, Tilly H, Sibon D.

Eur J Cancer. 2017 Sep;83:146-153. doi: 10.1016/j.ejca.2017.06.026. Epub 2017 Jul 20.

PMID:
28735072
20.

Actinic keratosis modelling in mice: A translational study.

Pillon A, Gomes B, Vandenberghe I, Cartron V, Cèbe P, Blanchet JC, Sibaud V, Guilbaud N, Audoly L, Lamant L, Kruczynski A.

PLoS One. 2017 Jun 29;12(6):e0179991. doi: 10.1371/journal.pone.0179991. eCollection 2017.

21.

No detection of Merkel cell polyomavirus in oral lichen planus: Results of a preliminary study in a French cohort of patients.

Masson Regnault M, Vigarios E, Projetti F, Herbault-Barres B, Tournier E, Lamant L, Sibaud V.

J Med Virol. 2017 Nov;89(11):2055-2057. doi: 10.1002/jmv.24887. Epub 2017 Jul 25.

PMID:
28661003
22.

[Drug eruption with clomifene citrate in a bodybuilder].

Severino-Freire M, Lamant L, Bagheri H, Mazereeuw-Hautier J, Paul C.

Ann Dermatol Venereol. 2017 Oct;144(10):636-637. doi: 10.1016/j.annder.2017.05.005. Epub 2017 Jun 20. French. No abstract available.

PMID:
28645464
23.

Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect.

Negulescu M, Deilhes F, Sibaud V, Tournier E, Lamant L, Boulinguez S, Meyer N.

Case Rep Dermatol. 2017 Mar 21;9(1):80-85. doi: 10.1159/000461571. eCollection 2017 Jan-Apr.

24.

Oral lichenoid reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings.

Sibaud V, Eid C, Belum VR, Combemale P, Barres B, Lamant L, Mourey L, Gomez-Roca C, Estilo CL, Motzer R, Vigarios E, Lacouture ME.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):e464-e469. doi: 10.1111/jdv.14284. Epub 2017 May 8. No abstract available.

25.

Systemic allergic contact dermatitis caused by methyl aminolaevulinate in a patient with keratosis-ichthyosis-deafness syndrome.

Al Malki A, Marguery MC, Giordano-Labadie F, Konstantinou MP, Mokeddem L, Lamant L, Paul C, Maza A, Mazereeuw-Hautier J.

Contact Dermatitis. 2017 Mar;76(3):190-192. doi: 10.1111/cod.12703. No abstract available.

PMID:
28220562
26.

Sclerosing sweat duct carcinoma of the penis in a 4-year-old child.

Abbo O, Gas J, Pinnagoda K, Tournier E, Bouali O, Castex MP, Lamant L, Galinier P.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26323. Epub 2016 Nov 1. No abstract available.

PMID:
27800657
27.

Photo-induced graft-versus-host disease.

Hardy JM, Marguery MC, Huynh A, Borel C, Apoil PA, Lamant L, Tournier E, Alberto C, Pauwels C, Thomas M, Mazereeuw Hautier J, Paul C, Bulai Livideanu C.

Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):291-295. doi: 10.1111/phpp.12273. Epub 2016 Oct 19.

PMID:
27623188
28.

Immunohistochemical staining for diagnosis of cutaneous mastocytosis.

Kirsten N, Tournier E, Lepage B, Lamant L, Hermine O, Paul C, Bulai Livideanu C.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):e160-e162. doi: 10.1111/jdv.13946. Epub 2016 Sep 12. No abstract available.

PMID:
27558023
29.

Tumour lysis syndrome: an unexpected adverse event associated with ipilimumab.

Masson Regnault M, Ofaiche J, Boulinguez S, Tournier E, Rochaix P, Paul C, Lamant L, Meyer N.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):e73-e74. doi: 10.1111/jdv.13733. Epub 2016 Jun 3. No abstract available.

PMID:
27256718
30.

MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma.

Menguy S, Gros A, Pham-Ledard A, Battistella M, Ortonne N, Comoz F, Balme B, Szablewski V, Lamant L, Carlotti A, Lorton MH, de Muret A, Le Gall F, Franck F, Croue A, Cappellen D, Beylot-Barry M, Merlio JP, Vergier B.

J Invest Dermatol. 2016 Aug;136(8):1741-1744. doi: 10.1016/j.jid.2016.04.018. Epub 2016 May 14. No abstract available.

31.

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies.

Sibaud V, Meyer N, Lamant L, Vigarios E, Mazieres J, Delord JP.

Curr Opin Oncol. 2016 Jul;28(4):254-63. doi: 10.1097/CCO.0000000000000290. Review.

PMID:
27136138
32.

Angiolymphoid hyperplasia with eosinophilia treated with low-dose methotrexate.

Alaidarous A, Bouissou X, Mazereeuw-Hautier J, Bulai-Livideanu C, Lamant L, Paul C.

JAAD Case Rep. 2015 Sep 27;1(6):342-4. doi: 10.1016/j.jdcr.2015.08.006. eCollection 2015 Nov. No abstract available.

33.

Anaplastic large cell lymphoma in paediatric and young adult patients.

Turner SD, Lamant L, Kenner L, Brugières L.

Br J Haematol. 2016 May;173(4):560-72. doi: 10.1111/bjh.13958. Epub 2016 Feb 23. Review.

PMID:
26913827
34.

Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.

Severino M, Chandesris MO, Barete S, Tournier E, Sans B, Laurent C, Apoil PA, Lamant L, Mailhol C, Laroche M, Fraitag S, Hanssens K, Dubreuil P, Hermine O, Paul C, Bulai Livideanu C.

J Am Acad Dermatol. 2016 May;74(5):885-91.e1. doi: 10.1016/j.jaad.2015.10.050. Epub 2016 Feb 19.

PMID:
26899198
35.

Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.

Bulai Livideanu C, Apoil PA, Lepage B, Eischen M, Laurent C, Laharrague P, Lamant L, Tournier E, Tavitian S, Pouplard C, Recher C, Laroche M, Mailhol C, Dubreuil P, Hermine O, Blancher A, Paul C.

Clin Exp Allergy. 2016 Jan;46(1):133-41. doi: 10.1111/cea.12627.

PMID:
26767494
36.

Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress.

Malcolm TI, Villarese P, Fairbairn CJ, Lamant L, Trinquand A, Hook CE, Burke GA, Brugières L, Hughes K, Payet D, Merkel O, Schiefer AI, Ashankyty I, Mian S, Wasik M, Turner M, Kenner L, Asnafi V, Macintyre E, Turner SD.

Nat Commun. 2016 Jan 12;7:10087. doi: 10.1038/ncomms10087.

37.

Highly Concordant Results Between Immunohistochemistry and Molecular Testing of Mutated V600E BRAF in Primary and Metastatic Melanoma.

Manfredi L, Meyer N, Tournier E, Grand D, Uro-Coste E, Rochaix P, Brousset P, Lamant L.

Acta Derm Venereol. 2016 Jun 15;96(5):630-4. doi: 10.2340/00015555-2326.

38.

Melanoma-expressed CD70 is involved in invasion and metastasis.

Pich C, Sarrabayrouse G, Teiti I, Mariamé B, Rochaix P, Lamant L, Favre G, Maisongrosse V, Tilkin-Mariamé AF.

Br J Cancer. 2016 Jan 12;114(1):63-70. doi: 10.1038/bjc.2015.412. Epub 2015 Dec 15.

39.

Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Laurent C, Delas A, Gaulard P, Haioun C, Moreau A, Xerri L, Traverse-Glehen A, Rousset T, Quintin-Roue I, Petrella T, Emile JF, Amara N, Rochaix P, Chenard-Neu MP, Tasei AM, Menet E, Chomarat H, Costes V, Andrac-Meyer L, Michiels JF, Chassagne-Clement C, de Leval L, Brousset P, Delsol G, Lamant L.

Ann Oncol. 2016 Feb;27(2):306-14. doi: 10.1093/annonc/mdv575. Epub 2015 Nov 23.

40.

Chemotherapy-Related Reticulate Hyperpigmentation: A Case Series and Review of the Literature.

Masson Regnault M, Gadaud N, Boulinguez S, Tournier E, Lamant L, Gladieff L, Roche H, Guenounou S, Recher C, Sibaud V.

Dermatology. 2015;231(4):312-8. doi: 10.1159/000439047. Epub 2015 Oct 1. Review.

PMID:
26422424
41.

Targeting autophagy enhances the anti-tumoral action of crizotinib in ALK-positive anaplastic large cell lymphoma.

Mitou G, Frentzel J, Desquesnes A, Le Gonidec S, AlSaati T, Beau I, Lamant L, Meggetto F, Espinos E, Codogno P, Brousset P, Giuriato S.

Oncotarget. 2015 Oct 6;6(30):30149-64. doi: 10.18632/oncotarget.4999.

42.

Acute skin reaction suggestive of pembrolizumab-induced radiosensitization.

Sibaud V, David I, Lamant L, Resseguier S, Radut R, Attal J, Meyer N, Delord JP.

Melanoma Res. 2015 Dec;25(6):555-8. doi: 10.1097/CMR.0000000000000191.

PMID:
26312439
43.

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.

Minard-Colin V, Brugières L, Reiter A, Cairo MS, Gross TG, Woessmann W, Burkhardt B, Sandlund JT, Williams D, Pillon M, Horibe K, Auperin A, Le Deley MC, Zimmerman M, Perkins SL, Raphael M, Lamant L, Klapper W, Mussolin L, Poirel HA, Macintyre E, Damm-Welk C, Rosolen A, Patte C.

J Clin Oncol. 2015 Sep 20;33(27):2963-74. doi: 10.1200/JCO.2014.59.5827. Epub 2015 Aug 24. Review.

44.

Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growth.

Hoareau-Aveilla C, Valentin T, Daugrois C, Quelen C, Mitou G, Quentin S, Jia J, Spicuglia S, Ferrier P, Ceccon M, Giuriato S, Gambacorti-Passerini C, Brousset P, Lamant L, Meggetto F.

J Clin Invest. 2015 Sep;125(9):3505-18. doi: 10.1172/JCI78488. Epub 2015 Aug 10.

45.

Cutaneous inflammatory myofibroblastic tumours can be anaplastic lymphoma kinase-positive: report of the first four cases.

Leguellec S, Tournier E, Karanian M, Brousset P, Mazereeuw J, Coindre JM, Lamant L.

Histopathology. 2016 Jan;68(2):297-302. doi: 10.1111/his.12759. Epub 2015 Aug 7.

PMID:
26100036
46.

The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors.

Delmas A, Cherier J, Pohorecka M, Medale-Giamarchi C, Meyer N, Casanova A, Sordet O, Lamant L, Savina A, Pradines A, Favre G.

Oncotarget. 2015 Jun 20;6(17):15250-64.

47.

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

de Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, Lamant L, Delarue R, Berger F, Arbion F, Bossard C, Copin MC, Canioni D, Charlotte F, Damaj G, Dartigues P, Fabiani B, Ledoux-Pilon A, Montagne K, Molina T, Patey M, Tas P, Peoch M, Petit B, Petrella T, Picquenot JM, Rousset T, Rousselet MC, Soubeyran I, Thiebault S, Tournilhac O, Xerri L, Gisselbrecht C, Haioun C, Delsol G, Gaulard P.

Haematologica. 2015 Sep;100(9):e361-4. doi: 10.3324/haematol.2015.126300. Epub 2015 Jun 4. No abstract available.

48.

Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.

Armand-Labit V, Meyer N, Casanova A, Bonnabau H, Platzer V, Tournier E, Sansas B, Verdun S, Thouvenot B, Hilselberger B, Doncescu A, Lamant L, Lacroix-Triki M, Favre G, Pradines A.

Acta Derm Venereol. 2016 Jan;96(1):29-34. doi: 10.2340/00015555-2156.

49.

ALK-positive anaplastic large cell lymphoma: an evolving story.

Bonzheim I, Steinhilber J, Fend F, Lamant L, Quintanilla-Martinez L.

Front Biosci (Schol Ed). 2015 Jun 1;7:248-59. Review.

PMID:
25961700
50.

Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC.

Strullu M, Thomas C, Le Deley MC, Chevance A, Kanold J, Bertrand Y, Jubert C, Dalle JH, Paillard C, Baruchel A, Lamant L, Michel G, Brugières L.

Bone Marrow Transplant. 2015 Jun;50(6):795-801. doi: 10.1038/bmt.2015.57. Epub 2015 Mar 30.

PMID:
25822227

Supplemental Content

Loading ...
Support Center